Supernus Pharma(SUPN) Receives Paragraph IV Notice Covering Generic Trokendi XR Filing
Tweet Send to a Friend
Supernus Pharmaceuticals (NASDAQ: SUPN) announced that on December 8, 2014 the Company received a Paragraph IV ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
